Debnath AK - Search Results

1

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

Jiang S, Lin K, Zhang L, Debnath AK. Jiang S, et al. Among authors: debnath ak. J Virol Methods. 1999 Jun;80(1):85-96. doi: 10.1016/s0166-0934(99)00041-5. J Virol Methods. 1999. PMID: 10403680

2

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

Debnath AK, Jiang S, Strick N, Lin K, Haberfield P, Neurath AR. Debnath AK, et al. J Med Chem. 1994 Apr 15;37(8):1099-108. doi: 10.1021/jm00034a007. J Med Chem. 1994. PMID: 8164251

3

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.

Neurath AR, Jiang S, Strick N, Lin K, Li YY, Debnath AK. Neurath AR, et al. Among authors: debnath ak. Nat Med. 1996 Feb;2(2):230-4. doi: 10.1038/nm0296-230. Nat Med. 1996. PMID: 8574970

4

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxis.

Neurath AR, Debnath AK, Strick N, Li YY, Lin K, Jiang S. Neurath AR, et al. Among authors: debnath ak. J Mol Recognit. 1995 Sep-Oct;8(5):304-16. doi: 10.1002/jmr.300080504. J Mol Recognit. 1995. PMID: 8619951

5

Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.

Neurath AR, Strick N, Debnath AK. Neurath AR, et al. Among authors: debnath ak. J Mol Recognit. 1995 Nov-Dec;8(6):345-57. doi: 10.1002/jmr.300080604. J Mol Recognit. 1995. PMID: 9052975

6

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1.

Debnath AK, Radigan L, Jiang S. Debnath AK, et al. J Med Chem. 1999 Aug 26;42(17):3203-9. doi: 10.1021/jm990154t. J Med Chem. 1999. PMID: 10464007

7

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

Jiang S, Debnath AK. Jiang S, et al. Among authors: debnath ak. Biochem Biophys Res Commun. 2000 Mar 24;269(3):641-6. doi: 10.1006/bbrc.1999.1972. Biochem Biophys Res Commun. 2000. PMID: 10720469 Review.

8

A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.

Jiang S, Debnath AK. Jiang S, et al. Among authors: debnath ak. Biochem Biophys Res Commun. 2000 Apr 2;270(1):153-7. doi: 10.1006/bbrc.2000.2411. Biochem Biophys Res Commun. 2000. PMID: 10733920

9

Peptide and non-peptide HIV fusion inhibitors.

Jiang S, Zhao Q, Debnath AK. Jiang S, et al. Among authors: debnath ak. Curr Pharm Des. 2002;8(8):563-80. doi: 10.2174/1381612024607180. Curr Pharm Des. 2002. PMID: 11945159 Review.

10

Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.

Neurath AR, Strick N, Jiang S, Li YY, Debnath AK. Neurath AR, et al. Among authors: debnath ak. BMC Infect Dis. 2002 Apr 30;2:6. doi: 10.1186/1471-2334-2-6. BMC Infect Dis. 2002. PMID: 11983022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters